Pharma Tariff Exposure: What’s at Stake as Implementation Approaches

The deadline for pharmaceutical manufacturers to secure onshoring agreements has passed, leaving several major drugmakers facing potential 100% tariffs beginning July 31, 2026. Learn which companies remain exposed and what the new U.S. tariff framework means for supply chains, sourcing, and compliance.